DE69627042D1 - Isocumarinderivate und deren verwendung in medikamenten - Google Patents

Isocumarinderivate und deren verwendung in medikamenten

Info

Publication number
DE69627042D1
DE69627042D1 DE69627042T DE69627042T DE69627042D1 DE 69627042 D1 DE69627042 D1 DE 69627042D1 DE 69627042 T DE69627042 T DE 69627042T DE 69627042 T DE69627042 T DE 69627042T DE 69627042 D1 DE69627042 D1 DE 69627042D1
Authority
DE
Germany
Prior art keywords
isocumar
medications
derivatives
pharmaceutical preparations
vascularization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69627042T
Other languages
English (en)
Other versions
DE69627042T2 (de
Inventor
Shin-Ichi Hirano
Toshiyuki Mase
Naoki Agata
Hiroshi Iguchi
Naoki Matsumoto
Takeo Yoshioka
Hiroshi Tone
Hiroyuki Kumagai
Masaaki Ishizuka
Tomio Takeuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Mercian Corp
Original Assignee
Microbial Chemistry Research Foundation
Mercian Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation, Mercian Corp filed Critical Microbial Chemistry Research Foundation
Application granted granted Critical
Publication of DE69627042D1 publication Critical patent/DE69627042D1/de
Publication of DE69627042T2 publication Critical patent/DE69627042T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69627042T 1994-12-19 1996-06-17 Isocumarinderivate und deren verwendung in medikamenten Expired - Fee Related DE69627042T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6333769A JPH08176138A (ja) 1994-12-19 1994-12-19 イソクマリン誘導体
PCT/JP1996/001657 WO1997048693A1 (fr) 1994-12-19 1996-06-17 Derives d'isocoumarine et utilisation de ces derniers dans des medicaments
CA002259621A CA2259621C (en) 1994-12-19 1996-06-17 Isocoumarin derivatives and their use in medicines

Publications (2)

Publication Number Publication Date
DE69627042D1 true DE69627042D1 (de) 2003-04-30
DE69627042T2 DE69627042T2 (de) 2003-11-20

Family

ID=27170918

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69627042T Expired - Fee Related DE69627042T2 (de) 1994-12-19 1996-06-17 Isocumarinderivate und deren verwendung in medikamenten

Country Status (9)

Country Link
US (1) US6020363A (de)
EP (1) EP0930310B1 (de)
JP (2) JPH08176138A (de)
AT (1) ATE235482T1 (de)
AU (1) AU6017296A (de)
CA (1) CA2259621C (de)
DE (1) DE69627042T2 (de)
ES (1) ES2190469T3 (de)
WO (1) WO1997048693A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010001270A (ko) 1999-06-03 2001-01-05 복성해 혈관신생을 억제하는 새로운 이소쿠마린 유도체
WO2001007429A1 (en) * 1999-07-22 2001-02-01 Mercian Corporation Process for producing isocoumarins and intermediates for the same
JP2001122870A (ja) * 1999-10-27 2001-05-08 Mercian Corp イソクマリン誘導体およびそれらの製造方法
US6473960B1 (en) 2000-01-07 2002-11-05 Storage Technology Corporation Method of making nitrided active elements
US6589981B2 (en) * 2000-02-29 2003-07-08 Ilex Oncology, Inc. Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives
US6900239B2 (en) * 2000-02-29 2005-05-31 Ilwz Ilex Products, Inc. Tumor chemopotentiation using isocoumarin derivatives
DE60140461D1 (de) * 2000-09-11 2009-12-24 Genzyme Corp Muc1 extrazelluläre domäne und zusammensetzungen für krebsbehandlung, und davon abgeleitete verfahren
US20040018181A1 (en) * 2000-09-11 2004-01-29 KUFE Donald W. MUC1 interference RNA compositions and methods derived therefrom
ES2282299T3 (es) 2000-10-20 2007-10-16 EISAI R&D MANAGEMENT CO., LTD. Compuestos aromaticos con anillos de nitrogeno como agentes anticancerigenos.
US6740406B2 (en) * 2000-12-15 2004-05-25 Kimberly-Clark Worldwide, Inc. Coated activated carbon
US20040166248A1 (en) * 2000-12-15 2004-08-26 Sheng-Hsin Hu Coated activated carbon
EP1958642A1 (de) * 2000-12-22 2008-08-20 Dana-Farber Cancer Institute Regulierung des Zellwachstums durch MUC1
US6900340B2 (en) * 2001-02-02 2005-05-31 Mercian Corporation Preparation of isocoumarin derivatives and intermediates for the synthesis thereof
US6664401B2 (en) 2001-07-06 2003-12-16 Ilex Products, Inc. Process for preparing isocoumarins
US20060122387A1 (en) * 2002-06-13 2006-06-08 Cti Europe S.R.L. Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells
WO2004092339A2 (en) * 2003-04-11 2004-10-28 Ilex Products, Inc. Modulation of muc1 mediated signal transduction
US8129506B2 (en) 2003-10-24 2012-03-06 Genzyme Corporation Modulation of the interaction of MUC1 with MUC1 ligands
CN100450998C (zh) 2003-11-11 2009-01-14 卫材R&D管理有限公司 脲衍生物的制备方法
EP1718367A1 (de) * 2004-02-23 2006-11-08 Genzyme Corporation Muc1-antagonisten-verstärkung von durch todes-rezeptor-ligand ausgelöster apoptose
JP4834553B2 (ja) 2004-09-17 2011-12-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 医薬組成物
JP4989476B2 (ja) 2005-08-02 2012-08-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 血管新生阻害物質の効果を検定する方法
RU2448708C3 (ru) 2006-05-18 2017-09-28 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Противоопухолевое средство против рака щитовидной железы
JP5368096B2 (ja) 2006-08-28 2013-12-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 未分化型胃癌に対する抗腫瘍剤
KR101445892B1 (ko) 2007-01-29 2014-09-29 에자이 알앤드디 매니지먼트 가부시키가이샤 미분화형 위암 치료용 조성물
WO2008097844A2 (en) * 2007-02-02 2008-08-14 Dana -Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of apoptosis by muc1 and bh3- containing proapoptotic proteins
US7972870B2 (en) 2007-02-02 2011-07-05 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3
CA2704000C (en) 2007-11-09 2016-12-13 Eisai R&D Management Co., Ltd. Combination of anti-angiogenic substance and anti-tumor platinum complex
US9012458B2 (en) 2010-06-25 2015-04-21 Eisai R&D Management Co., Ltd. Antitumor agent using compounds having kinase inhibitory effect in combination
CA2828946C (en) 2011-04-18 2016-06-21 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
ES2841809T3 (es) 2011-06-03 2021-07-09 Eisai R&D Man Co Ltd Biomarcadores para pronosticar y evaluar el grado de respuesta de sujetos con cáncer de tiroides y de riñón a compuestos de lenvatinib
MX2015004979A (es) 2012-12-21 2015-07-17 Eisai R&D Man Co Ltd Forma amorfa de derivado de quinolina y metodo para su produccion.
AU2014266223B2 (en) 2013-05-14 2020-06-25 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
ES2926687T3 (es) 2014-08-28 2022-10-27 Eisai R&D Man Co Ltd Derivado de quinolina muy puro y método para su producción
HUE064614T2 (hu) 2015-02-25 2024-04-28 Eisai R&D Man Co Ltd Eljárás egy kinolin-származék keserû ízének elnyomására
KR102662228B1 (ko) 2015-03-04 2024-05-02 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
AU2016279474B2 (en) 2015-06-16 2021-09-09 Eisai R&D Management Co., Ltd. Anticancer agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2802097B2 (ja) * 1989-05-31 1998-09-21 財団法人微生物化学研究会 新規な制癌抗生物質ｍｉ４３―３７ｆ１１及びその製造法
JP3041022B2 (ja) * 1990-08-31 2000-05-15 メルシャン株式会社 抗性物質ｍ１４３―３７ｆ１１の製造方法及び製造中間体
JPH0597841A (ja) * 1991-10-04 1993-04-20 Mercian Corp イソクマリン誘導体
JP3233709B2 (ja) * 1992-12-18 2001-11-26 メルシャン株式会社 免疫調節剤

Also Published As

Publication number Publication date
EP0930310A4 (de) 2001-08-22
JPH08176138A (ja) 1996-07-09
US6020363A (en) 2000-02-01
ATE235482T1 (de) 2003-04-15
JP3150709B2 (ja) 2001-03-26
DE69627042T2 (de) 2003-11-20
EP0930310B1 (de) 2003-03-26
CA2259621A1 (en) 1997-12-24
EP0930310A1 (de) 1999-07-21
WO1997048693A1 (fr) 1997-12-24
CA2259621C (en) 2007-09-18
ES2190469T3 (es) 2003-08-01
AU6017296A (en) 1998-01-07

Similar Documents

Publication Publication Date Title
DE69627042D1 (de) Isocumarinderivate und deren verwendung in medikamenten
ATE175669T1 (de) Sulfonylaminopyrimidine, ihre herstellung und verwendung als heilmittel
ATE494009T1 (de) Prodrugs, ihre herstellung und verwendung als arzneimittel
DE69423139T2 (de) Amid-Derivate mit anti-hypercholesterolemischer Wirkung, deren Herstellung und deren Verwendungen als Heilmittel
ATE142630T1 (de) Triazin-derivate und unkrautvertilgungsmittel daraus
DE69418243D1 (de) N-Heteroaryl-N'-Phenylharnstoffderivate, ihre Herstellung und Verwendung
ATE170510T1 (de) 3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel
ATE94869T1 (de) Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika.
ATE143935T1 (de) Arylcycloalkylderivate, deren herstellung und verwendung
FI935728A (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
NO179834C (no) Substituerte cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler
ATE172975T1 (de) Benzimidezolderivate mit antidiabetischer und anti-plättchenklumpungswirkung
ATE131817T1 (de) 2,4-pyrimidindionderivate und diese enthaltende arzneimittel
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
ATE139523T1 (de) Neue verbindungen und deren medizinale verwendung
DE3870167D1 (de) N-(vinblastinoyl-23)-derivate von 1-aminomethylposphonsaeure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
ATE209633T1 (de) Pyridinderivate,als arzneimittel zur behandlung von geschwüren und als antibakterielle mittel
DE69130266D1 (de) Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel
ATE184282T1 (de) Cyclopropan-derivate und diese enthaltende antivirale mittel
DE3675758D1 (de) 5-aminoalkyl-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel.
DE3862660D1 (de) 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel.
DE69218205D1 (de) 1,2,4-THIADIAZINO[3,4-b]BENZOTHIAZOL-DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL
DE59003446D1 (de) 13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln.
FI933928A (fi) Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee